| Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis EP Harausz, AJ Garcia-Prats, S Law, HS Schaaf, T Kredo, JA Seddon, ... PLoS medicine 15 (7), e1002591, 2018 | 145 | 2018 |
| New and repurposed drugs for pediatric multidrug-resistant tuberculosis. Practice-based recommendations EP Harausz, AJ Garcia-Prats, JA Seddon, HS Schaaf, AC Hesseling, ... American journal of respiratory and critical care medicine 195 (10), 1300-1310, 2017 | 82 | 2017 |
| Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis S Abidi, J Achar, MMA Neino, D Bang, A Benedetti, S Brode, JR Campbell, ... European Respiratory Journal 55 (3), 2020 | 70 | 2020 |
| Ebola viral disease and pregnancy BO Black, S Caluwaerts, J Achar Obstetric Medicine 8 (3), 108-113, 2015 | 65 | 2015 |
| Prognostic indicators for Ebola patient survival SJ Crowe, MJ Maenner, S Kuah, BR Erickson, M Coffee, B Knust, J Klena, ... Emerging infectious diseases 22 (2), 217, 2016 | 63 | 2016 |
| Off-label use of bedaquiline in children and adolescents with multidrug-resistant tuberculosis J Achar, C Hewison, AP Cavalheiro, A Skrahina, J Cajazeiro, P Nargiza, ... Emerging infectious diseases 23 (10), 1711, 2017 | 59 | 2017 |
| Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needs C Ssonko, L Gonzalez, A Mesic, MS da Fonseca, J Achar, N Safar, ... Journal of the International AIDS Society 20, 21654, 2017 | 36 | 2017 |
| Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a … T Shah, J Greig, LM van der Plas, J Achar, G Caleo, JS Squire, AS Turay, ... The Lancet Global Health 4 (7), e495-e501, 2016 | 31 | 2016 |
| Person-centred care in practice: Perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan S Horter, B Stringer, N Gray, N Parpieva, K Safaev, Z Tigay, J Singh, ... BMC Infectious Diseases 20, 1-11, 2020 | 23 | 2020 |
| Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB. Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic … EP Harausz, AJ Garcia-Prats, S Law, HS Schaaf, T Kredo, JA Seddon, ... PLoS Med 15 (7), e1002591, 2018 | 23 | 2018 |
| Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan JM Trauer, J Achar, N Parpieva, A Khamraev, JT Denholm, D Falzon, ... BMC medicine 14, 1-11, 2016 | 23 | 2016 |
| Electronic medical records in humanitarian emergencies–the development of an Ebola clinical information and patient management system K Jobanputra, J Greig, G Shankar, E Perakslis, R Kremer, J Achar, ... F1000Research 5, 2016 | 19 | 2016 |
| Treatment outcomes in global systematic review and patient meta-analysis of children with extensively drug-resistant tuberculosis M Osman, EP Harausz, AJ Garcia-Prats, HS Schaaf, BK Moore, RM Hicks, ... Emerging infectious diseases 25 (3), 441, 2019 | 18 | 2019 |
| Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications A Swaminathan, P Du Cros, JA Seddon, S Quinnell, OI Bobokhojaev, ... The International Journal of Tuberculosis and Lung Disease 20 (4), 474-478, 2016 | 17 | 2016 |
| Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014–15 G Theocharopoulos, K Danis, J Greig, A Hoffmann, H De Valk, A Jimissa, ... PLoS One 12 (5), e0176692, 2017 | 16 | 2017 |
| Treatment of rifampicin-resistant tuberculosis disease and infection in children: key updates, challenges and opportunities P Howell, J Achar, GKL Huang, A Mariandyshev, HS Schaaf, ... Pathogens 11 (4), 381, 2022 | 15 | 2022 |
| Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data L Ranasinghe, J Achar, MI Gröschel, E Whittaker, PJ Dodd, JA Seddon The Lancet Global Health 10 (12), e1774-e1781, 2022 | 13 | 2022 |
| Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan P du Cros, A Khamraev, Z Tigay, T Abdrasuliev, J Greig, G Cooke, ... ERJ Open Research 7 (1), 2021 | 13 | 2021 |
| Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan J Kuhlin, C Smith, A Khaemraev, Z Tigay, N Parpieva, M Tillyashaykhov, ... The international journal of tuberculosis and lung disease 22 (5), 544-550, 2018 | 11 | 2018 |
| Multidrug-resistant tuberculosis in child successfully treated with 9-month drug regimen J Achar, C Berry, K Herboczek, N Parpieva, MN Tillyashaykhov, ZN Tigay, ... Emerging Infectious Diseases 21 (11), 2105, 2015 | 11 | 2015 |
